Position in VRTX
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$1,474,294
+$259,706 QoQ
Shares Held
2,968
+9.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#749
of 1,732 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026IFP Advisors, Inc holds $55,990,065 across 216 Biotechnology names. VRTX ranks #7 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AXSM |
Axsome Therapeutics, Inc.
|
62,273 | $15,242,562 | |
| 2 | TGTX |
Tg Therapeutics, Inc.
|
209,318 | $11,499,930 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
34,193 | $8,239,487 | |
| 4 | AUPH |
Aurinia Pharmaceuticals Inc.
|
361,634 | $6,136,928 | |
| 5 | VKTX |
Viking Therapeutics, Inc.
|
61,616 | $2,403,640 | |
| 6 | EXEL |
Exelixis, Inc.
|
43,101 | $2,345,125 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
2,968 | $1,474,294 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,352 | $843,026 |
All Filings in VRTX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,474,294 | 2,968 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $1,214,588 | 2,720 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $1,397,255 | 3,082 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $894,897 | 2,285 | Shares | Sole | 2026-02-06 | |
| 2025-06-30 | $707,868 | 1,590 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $1,291,560 | 2,664 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $1,109,841 | 2,756 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $859,002 | 1,847 | Shares | Sole | 2025-02-04 | |
| 2024-06-30 | $1,079,930 | 2,304 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $825,987 | 1,976 | Shares | Sole | 2024-07-30 | |
| 2023-12-31 | $868,710 | 2,135 | Shares | Sole | 2024-01-09 | |
| 2023-09-30 | $619,324 | 1,781 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $652,441 | 1,854 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $493,084 | 1,565 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $1,098 | 6,904 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $2,387,836 | 8,247 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $2,123,569 | 7,536 | Shares | Sole | 2022-09-06 | |
| 2022-03-31 | $300,376 | 1,151 | Shares | Sole | 2022-08-08 | |
| 2021-12-31 | $243,756 | 1,110 | Shares | Sole | 2022-01-12 | |
| 2021-09-30 | $211,137 | 1,164 | Shares | Sole | 2021-10-06 | |
| 2021-06-30 | $203,646 | 1,010 | Shares | Sole | 2021-07-13 | |
| 2021-03-31 | $391,959 | 1,824 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $530,583 | 2,245 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $605,739 | 2,226 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $371,887 | 1,281 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $236,760 | 995 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||